US:ISPH - Get Stock quote detail for Inspire Pharmaceuticals Inc. Stock quotes include the latest US:ISPH market price and fundamental investing data,

Jobs 1 - 10 of 598 . 598 Inspire Pharmaceuticals Jobs available on Indeed.com. one search. all jobs.

Jan 3, 2011 . The company, which just moved to Raleigh, says its candidate for treatment of cystic fibrosis fails to meet efficacy goals in Phase III .

Diquafosol Drug Information from Drugs.com. Includes side effects, interactions, indications.

Jan 3, 2011 . What: The new trading year came in with a loud thud for Inspire Pharmaceuticals (Nasdaq: ISPH ) when its stock fell 58% this morning. .

Break In to Pharmaceutical Sales . Reload this Page Inspire Pharmaceuticals . Threads in Forum : Inspire Pharmaceuticals, Forum Tools .

Apr 5, 2011 . Merck to Acquire Inspire Pharmaceuticals, Inc. Expands and positions ophthalmology portfolio for future growth .

Durham, N.C. based Inspire Pharmaceuticals, Inc. (ISPH) is a specialty pharmaceutical company engaged in the development and commercialization of.

Dec 6, 2006 . Shareholder alert for Inspire Pharmaceuticals Inc. from M2 Presswire. HighBeam Research – FREE Trial.

Merck (NYSE:MRK) announced today a definitive agreement to acquire Inspire Pharmaceuticals Inc (NASDAQ:ISPH) for $5.00 per share in cash, which represents a .

Inspire is a biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and .

Inspire Pharmaceuticals Inc. financial and business news, updates, and information from The New York Times and other leading providers.

Jan 3, 2011 . Some interesting news flow today related to the failure in Phase III of Inspire Pharmaceuticals cystic fibrosis drug denufosol tetrasodium. .

Nov 29, 2009 . Exhibit 10.43 TRANSITION AGREEMENTThis Transition Agreement (this “ Agreement ”) , is made by and between Gregory J. Mossinghoff, .

Hoovers company profile of Inspire Pharmaceuticals, Inc.. Find detailed business information such as key executives, financials and other corporate data on .

Apr 5, 2011 . Expands and positions ophthalmology portfolio for future growth WHITEHOUSE STATION, N.J. & RALEIGH, N.C., Apr 05, 2011 (BUSINESS WIRE) .

May 17, 2011 . {Avakado via BioPortfolio} Merck & Co has completed its acquisition of Inspire Pharmaceuticals, a speciality pharmaceutical company focused .

Apr 28, 2011 . Earlier this week, he notched a deal to sell Inspire Pharmaceuticals ( ISPH ), where he is CEO, to Merck for $430 million, or $5 a share, .

May 13, 2011 . WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (

Apr 6, 2011 . Inspire Pharmaceuticals Inc. (ISPH) is a specialty pharmaceutical company focused on developing and commercializing ophthalmic products.

Apr 28, 2011 . Inspire Pharmaceuticals has asked the court to dismiss a shareholder lawsuit that claims that Merck's $430 million offer to acquire the .

Apr 5, 2011 . Dayton, OH News - View Daily Local Business News, Resources & more in Dayton, Ohio.

Apr 3, 2002 . Free Online Library: Inspire Pharmaceuticals, Inc. Initiates New Phase III Clinical Trial In Dry Eye Program; - FDA Agrees to New, .

Icon attached Review or Hide All RxNorm Normal Forms Link Review RxNorm Normal Forms. AZASITE (azithromycin) solution [Inspire Pharmaceuticals, Inc.] .

May 16, 2011 . Merck Completes Acquisition of Inspire Pharmaceuticals, Inc. from Business Wire provided by Find Articles at BNET.

If you purchased Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) and currently continue to hold those NASDAQ:ISPH shares, and/or if you have any information .

Apr 7, 2011 . Azasite, Elestat and Restasis among treatments in Inspire portfolio.

Apr 5, 2011 . Levi & Korsinsky is a national law firm thatrepresents the rights of shareholders and victims of corporate abuse.

From staff reports RALEIGH -- Whitehouse Station, N.J-based Merck has plans to acquire the Raleigh-based Inspire Pharmaceuticals Inc. for a transaction .

Dec 12, 2008 . Plaintiffs' primary allegation is that Inspire Pharmaceuticals, Inc. committed securities fraud by overstating the prospects for an .

Jan 3, 2011 . Phase 3 clinical trial data negative for denusofol in cystic fibrosis.

Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH). + Watch ISPH. on My Watchlist. $5.01 0.00 (0%). 5/13/2011 4:00 PM .

JAZZ, Jazz Pharmaceuticals Inc. NASDAQ. SOXX, iShares PHLX SOX Semiconductor Sector Index Fund, NASDAQ. JAZZ, Jazz Pharmaceuticals Inc. NASDAQ .

May 16, 2011 . Merck , known as MSD outside the United States and Canada, announced today that it is has completed its acquisition of Inspire .

Jan 6, 2011 . Inspire Pharmaceuticals (ISPH) started the new year in the worst possible fashion. Shares in the North Carolina group lost more than half .

May 16, 2011 . Merck & Co. said Monday it completed its $430 million purchase of eye-drug maker Inspire Pharmaceuticals Inc.

Apr 12, 2011 . An Inspire Pharmaceuticals Inc. shareholder filed a lawsuit claiming Merck & Co. 's $430 million offer for the company is inadequate.

May 10, 2011 . The Durham, N.C.-based biopharmaceutical company posted a net loss of $17.6 million, or 21 cents a share, compared with a loss of $14.8 .

May 16, 2011 . Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that it is has completed its acquisition of Inspire .

Jan 3, 2011 . Shares of Inspire Pharmaceuticals were cut in half Monday morning after the company reported that its experimental cystic fibrosis drug .

Aug 25, 2010 . "Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) has put a halt to the development of the dry eye disease drug Prolacria and has amended its .

Inspire's partner, Santen Pharmaceutical Co., Ltd. is developing diquafosol tetrasodium in Japan and nine other Asian countries. .

A description of Merck's Acquisition of Inspire Pharmaceuticals a provider of ophthalmic products.

Message Boards: ISPH (Inspire Pharmaceuticals). Tweet This · chart. ISPH ( Inspire Pharmaceuticals - Msgs, Twts, Profile) .

Find ISPH stock information including current INSPIRE PHARMACEUTICALS INC stock quote, stock price, and more.

May 17, 2011 . Merck, known as MSD outside the United States and Canada, announced today that it is has completed its acquisition of Inspire .

Apr 5, 2011 . CHICAGO (Reuters) - Merck & Co said on Tuesday it would acquire eye treatment maker Inspire Pharmaceuticals Inc for about $430 million to .

Oct 20, 2008 . See what employees say it's like to work at Inspire Pharmaceuticals. Salaries, reviews, and more - all posted by employees working at .

Jun 18, 2011 . Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance.

Sitemap